Latest price-to-book ratio
SAB Biotherapeutics Price-to-book ratio
Direct answer
SAB Biotherapeutics's price-to-book ratio is 1.1x.
The verified market snapshot reports 1.1x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 24, 2026.
Get free SAB Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 1.1x
Explore related company data
View SAB Biotherapeutics's market capitalizationView SAB Biotherapeutics's return on equityView SAB Biotherapeutics's dividend yieldView SAB Biotherapeutics's 52-week price rangeView SAB Biotherapeutics's profit marginView SAB Biotherapeutics's debt-to-equity ratioView all SAB Biotherapeutics key metricsReturn to SAB Biotherapeutics profile